DIA, Monaco
March 8 2010 - March 10 2010
Date(s) And Time(s):
Mar 8 2010 8:00AM - Mar 10 2010 6:00PM
Location:
Grimaldi Forum
10, avenue Princesse Grace
BP 2000
Monaco, 98000
Monaco
The Drug Information Association’s Annual EuroMeeting is global in scope, attracting well over 3,000 professionals from over 50 countries. It brings together professionals from the biopharmaceutical industry,contract service organisations, academic research centres, regulatory agencies and health ministries. The 22nd Annual EuroMeeting provides unique opportunities to:
* Attend presentations by more than 350 speakers
* Hear representatives from the EMEA, FDA and regulatory agencies throughout Europe
* Attend preconference tutorials
* Network with professional colleagues from around the world
* Visit more than 200 exhibitors in Europe’s largest interactive exhibit hall
* Choose from hot-topic sessions in 13 themes: - Theme 1: Innovation
Is an Open Innovation Paradigm the Way Forward for Pharma?
- Theme 2: Staying in Business: How to Make Sure You Comply with All Rules and Regulations, Quality, Compliance, and External Challenges
The Price of Globalisation: Bringing Modern Therapies to Developing Countries or Only Including Patients in Trials? What Should We All Know About Indian Society, Medical Practice and Patients Before Drawing Conclusions?
- Theme 3: Paediatric Medicines on Their Way to Patients
Initial Impact of the Paediatric Regulation After 3 Years
- Theme 4: Decision Making: The Key to Efficient and Effective Drug Development, approval, and access
Influence of HTA on Regulatory Decision-Making: Reality? Opportunity? Threat?
- Theme 5: Paving the Way for Advanced Therapies: Fostering New Generations of Biotechnology-Derived Medicines
CAT Experience in the First Year
- Theme 6: Challenges for Switching from Prescription to Non-Prescription Status through the Centralised Procedure
Could the UK Model Be Reproduced at EU Level?
- Theme 7: Personalised Medicines: What Is It, Where Do We Stand, and Where Are We Going?
The EMEA’s New Biomarker Qualification Process: How Does It Work and Where Does It Fit?
- Theme 8: Taking the European Regulatory Infrastructure Forward
Pharmaceutical Package - The Latest Information
- Theme 9: Risk Management
Research Initiatives in Risk Management|
- Theme 10: The Informed Patient
Pharmaceutical Package: Information to Patient Proposals - What Difference Will They Make?
- Theme 11: eHealth
Connecting Healthcare and Clinical Research
- Theme 12: Pharmaceutical Sciences in 2020
What Major Research Activities Will Drive Drug Discovery and Development?
- Theme 13: Handling Clinical Trials, eSubmissions and Quality Requests
Emerging Standards from ICH
|
|